US Mass Spectrometry Market

The US mass spectrometry market is projected to grow from USD 2.42 billion in 2025 to USD 3.55 billion by 2031, at a CAGR of 6.7% during this period.

The US market growth is driven by recent advancements in genomic sequencing and biomarker identification, the shift of big pharma companies away from one-size-fits-all drugs to precision medicine, and their expanding R&D pipeline, rigorous mandates of regulatory bodies related to bioanalytical method validation, and other drug development workflows. Also, LC-MS/MS and GC-MS have become gold-standard compliance tools for these studies, particularly for low-level drug quantification in complex biological matrices. For instance, in 2024, the EPA (US) enforced PFAS testing regulations for drinking water, setting legally enforceable maximum contaminant levels for PFOA and PFOS, which requires testing by specific platforms (mainly LC-MS). Such developments contribute to increased test volumes that require mass spectrometry instruments in the US.

To know about the assumptions considered for the study download the pdf brochure

The competitive landscape for the US mass spectrometry market is composed of some strong players that acquire a significant share of the market, while at the same time, some of the SME's hold a measurable position in the market. Major players that operate in the mass spectrometry market are Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Waters Corporation (US), Bruker Corporation (US), Shimadzu Corporation (Japan), PerkinElmer, Inc (US), Jeol, Ltd (Japan), Jasco (Japan), Teledyne Technologies Incorporated (US), and MKS Instruments (US).

The main growth strategies used by leading companies in this market include product approvals and launches, acquisitions, collaborations, partnerships, and agreements. Over the past three years, product approvals and launches have been the most popular organic growth strategies adopted by market players seeking to increase their share of the market.

Agilent Technologies, Inc. (US)

Agilent Technologies offers a comprehensive portfolio of LC-MS, GC-MS, and ICP-MS in the mass spectrometry market. The company has a strong presence in North America and Europe. Over the last few years, the company has increased its R&D activities with a focus on investing a significant amount of its revenue in R&D. It will continue to have substantial research & development expenditures to maintain its competitive position with a continuing flow of innovative, high-quality products and services. The company is also focusing on acquisitions, collaborations, and expansions to maintain its position in the market.

Thermo Fisher Scientific, Inc. (US)

Thermo Fisher is a US-based company that offers a complete and integrated portfolio of solutions and services for laboratory research & analysis, healthcare & clinical science, manufacturing, and other fields. The company operates through four business segments, namely Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. The Analytical Instruments business segment offers mass spectrometry products. Thermo Fisher, being a major player, can be attributed to its extensive portfolio of mass spectrometry equipment used for various applications. It focuses on expanding its product portfolio by introducing new and advanced mass spectrometers for customers in biotechnology, pharmaceuticals, toxicology, forensics, and other fields.

Waters Corporation (US)
Waters Corporation is among the prominent players in the mass spectrometry market. They specialize in liquid chromatography, mass spectrometry (MS), and thermal analysis systems, striving to advance scientific research worldwide. The offering for mass spectrometry covers all significant types of analyzers, like quadrupoles and time of flight. Their MS portfolio includes technologies like QuanTof for high-resolution exact mass measurements, StepWave for trace component confirmation, Triwave for complex mixture characterization, and MS E for exact-mass ion spectra from samples. The company focuses on innovation, performance, and usability.

Market Ranking

The US mass spectrometry market is moderately consolidated, with a limited group of global vendors capturing a significant share of revenues through broad instrument portfolios and entrenched installed bases. Thermo Fisher Scientific, Agilent Technologies, and Waters stand out as the principal participants, combining extensive LC-MS/MS product lines with clinical-grade software, assay packages, and service infrastructure that are embedded in hospital, reference, and contract testing laboratories worldwide. A second tier of manufacturers, including Shimadzu and Bruker, contributes meaningfully to market supply through high-performance LC-MS and hybrid MS systems that are increasingly adapted to clinical workflows, often focusing on specific regions or application niches.

Related Reports:

US Mass Spectrometry Market by Component (Detector, Mass Analyzer, Ion Source, Vacuum System), Product [Triple Quad, Q-ToF, FTMS, Quad, ToF], Application (Omics, Clinical, Environment, F&B, Pharma), Installed Base & Replacement Rate - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com